Pozelimab [2096328-94-6]

TargetMol Chemicals

Pozelimab

9

2096328-94-6

Antibody

Research Use Only

Pozelimab

Pozelimab (REGN3918), a fully human IgG4 monoclonal antibody, is designed to target and bind with high affinity to both C5 and its variants, effectively inhibiting complement-mediated hemolysis. It holds potential for research into complement-mediated diseases [1].

3 years

-20°C

12352203